Cryptogenic Stroke
27
7
11
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 27 trials
100.0%
+13.5% vs benchmark
4%
1 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (27)
Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure
Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study
Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Stroke of Unknown Cause in Women: The Impact of Long-term Heart Monitoring on Stroke Recurrence
Incidence and Predictors of Recurrent Stroke in Cryptogenic Stroke Patients With Atrial Fibrillation
Comparison of Lower vs Upper Extremity Injection Agitated Saline to Identify Patent Foramen Ovale With Echocardiography
Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study
Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke
Improving AF Detection in Cryptogenic Stroke
Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence
ConfirmRxTM: Posture and Activity
Master Study of the BIOMONITOR III and Incision and Insertion Tool (FIT OneStep)
LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study
Encore PFO Closure Device - The PerFOrm Trial
Atrial Anomalies Predict Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Cryptogenic Stroke
Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia
Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders.
Safety and Efficacy of IrisFIT™ Patent Foramen Ovale Occluders
Early Detection of Atrial Fibrillation Using Mobile Technology in Cryptogenic Stroke Patients